You just read:

Synthorx to Present Preclinical Data for THOR-707, a "Not-Alpha" IL-2 Synthorin, for the Treatment of Solid Tumors at SITC 2018

News provided by

Synthorx, Inc.

Nov 09, 2018, 08:01 ET